Qirong Geng

686 total citations
27 papers, 469 citations indexed

About

Qirong Geng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Qirong Geng has authored 27 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in Qirong Geng's work include Gastric Cancer Management and Outcomes (9 papers), Metastasis and carcinoma case studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Qirong Geng is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Metastasis and carcinoma case studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Qirong Geng collaborates with scholars based in China and United States. Qirong Geng's co-authors include Dazhi Xu, Youqing Zhan, Pengfei Kong, Yue Lu, Xiaowei Sun, Yingbo Chen, Jianjun Liu, Weida Wang, Shangxiang Chen and Hua Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Qirong Geng

25 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qirong Geng China	12	172	158	119	117	112	27	469
Meiling Zhu China	14	199 1.2×	156 1.0×	96 0.8×	92 0.8×	137 1.2×	25	410
Eugenio Fiorentino Italy	15	209 1.2×	156 1.0×	176 1.5×	177 1.5×	149 1.3×	41	572
Takeshi Toyozumi Japan	13	249 1.4×	137 0.9×	128 1.1×	168 1.4×	136 1.2×	62	496
Adrian Goldiș Romania	11	133 0.8×	157 1.0×	110 0.9×	91 0.8×	146 1.3×	27	408
Hai-Bo Qiu China	10	133 0.8×	120 0.8×	87 0.7×	75 0.6×	80 0.7×	14	366
Poh Seng Tan Singapore	12	156 0.9×	80 0.5×	128 1.1×	124 1.1×	67 0.6×	26	541
Ruixuan Geng China	12	234 1.4×	196 1.2×	58 0.5×	148 1.3×	254 2.3×	29	556
Yasuhiro Arakawa Japan	11	150 0.9×	86 0.5×	90 0.8×	94 0.8×	159 1.4×	37	380
Hiroyuki Maeta Japan	11	191 1.1×	79 0.5×	56 0.5×	96 0.8×	146 1.3×	24	419
Chun-yu Huang China	10	143 0.8×	164 1.0×	121 1.0×	72 0.6×	179 1.6×	13	429

Countries citing papers authored by Qirong Geng

Since Specialization

Citations

This map shows the geographic impact of Qirong Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qirong Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qirong Geng more than expected).

Fields of papers citing papers by Qirong Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qirong Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qirong Geng. The network helps show where Qirong Geng may publish in the future.

Co-authorship network of co-authors of Qirong Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Qirong Geng. A scholar is included among the top collaborators of Qirong Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qirong Geng. Qirong Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geng, Qirong, Hua Huang, Xiaoying Zhao, et al.. (2025). Conversion effects of PD-1 inhibitor camrelizumab (Cam) combined with Nab-POF regimen in patients (pts) with initially unresectable locally advanced or limited metastatic gastric or gastroesophageal junction adenocarcinoma: FDZL-001 trial.. Journal of Clinical Oncology. 43(4_suppl). 334–334.

Huang, Mingzhu, Yanan Yang, Qingguo Li, et al.. (2022). Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases. Frontiers in Oncology. 12. 747124–747124. 5 indexed citations

Wang, Chenchen, Mingzhu Huang, Qirong Geng, et al.. (2021). Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study. Therapeutic Advances in Medical Oncology. 13. 4277451079–4277451079. 2 indexed citations

Geng, Qirong, et al.. (2020). Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes. The Journal of Pathology. 252(3). 263–273. 11 indexed citations

Liu, Chengcheng, Hua Wang, Weida Wang, et al.. (2018). ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia. Cellular Physiology and Biochemistry. 46(4). 1525–1535. 65 indexed citations

Liu, Jianjun, Qirong Geng, Xuechao Liu, et al.. (2017). Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection. OncoTargets and Therapy. Volume 10. 2155–2162. 30 indexed citations

Chen, Shangxiang, Jianjun Liu, Qirong Geng, et al.. (2017). Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes. Oncotarget. 8(28). 45585–45596. 11 indexed citations

Geng, Qirong, Jianjun Liu, Zhaohui Gong, et al.. (2017). Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer. Molecular Cancer. 16(1). 83–83. 21 indexed citations

Kong, Pengfei, Xiao‐Feng Zhu, Qirong Geng, et al.. (2017). The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Molecular Therapy. 25(4). 1027–1037. 51 indexed citations

10.

Kong, Pengfei, Ruiyan Wu, Chenlu Yang, et al.. (2016). Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer. Scientific Reports. 6(1). 26313–26313. 14 indexed citations

11.

Liu, Jianjun, Qirong Geng, Zhimin Liu, et al.. (2016). Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry. Oncotarget. 7(24). 35853–35864. 38 indexed citations

12.

Cai, Qingqing, Kailin Chen, Jie Chen, et al.. (2016). The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy. PLoS ONE. 11(10). e0164210–e0164210. 9 indexed citations

13.

Xia, Zhongjun, Hua Wang, Liang Wang, et al.. (2016). Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients. OncoTargets and Therapy. 9. 587–587. 8 indexed citations

14.

Lv, Yue, Cheng‐Cheng Liu, Hua Wang, et al.. (2015). Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia. OncoTargets and Therapy. 8. 3297–3297. 6 indexed citations

15.

Kong, Pengfei, Qingqing Cai, Qirong Geng, et al.. (2014). Vitamin Intake Reduce the Risk of Gastric Cancer: Meta-Analysis and Systematic Review of Randomized and Observational Studies. PLoS ONE. 9(12). e116060–e116060. 58 indexed citations

16.

Zhang, Jing, Hua Wang, Liang Wang, et al.. (2013). Adenovirus-mediated delivery of the human IFN-γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway. Oncology Letters. 7(2). 361–368. 2 indexed citations

17.

Yang, Hui, Carlos E. Bueso‐Ramos, Simrit Parmar, et al.. (2012). Induction of PD-1 and PD-1 Ligand Expression by Hypomethylating Agents (HMA) in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Suggest a Role for T Cell Function in Clinical Resistance to Hmas. Blood. 120(21). 3810–3810. 2 indexed citations

18.

Xu, Dazhi, Ying Huang, Qirong Geng, et al.. (2012). Effect of Lymph Node Number on Survival of Patients with Lymph Node-Negative Gastric Cancer according to the 7th Edition UICC TNM System. PLoS ONE. 7(6). e38681–e38681. 47 indexed citations

19.

Wang, Liang, Panpan Liu, Xiaoqin Chen, Qirong Geng, & Yue Lu. (2011). Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. Medical Oncology. 29(3). 2153–2158. 16 indexed citations

20.

Chen, Xiaoqin, et al.. (2010). Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of β₁-integrin in K562 chronic myelogenous leukemia cell line. Leukemia & lymphoma. 51(6). 1090–1097. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact